An E3 ubiquitin-proteasome gene signature for predicting prognosis in patients with pancreatic cancer.

MLA

Yin, Taoyuan, et al. “An E3 Ubiquitin-Proteasome Gene Signature for Predicting Prognosis in Patients with Pancreatic Cancer.” Frontiers in Immunology, vol. 14, Jan. 2024, p. 1332626. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1332626.

APA

Yin, T., Wen, J., Xu, S., Chen, L., Zhang, Z., Pan, S., Zhou, M., Guo, X., Wang, M., Gong, J., Zhang, H., & Qin, R. (2024). An E3 ubiquitin-proteasome gene signature for predicting prognosis in patients with pancreatic cancer. Frontiers in Immunology, 14, 1332626. https://doi.org/10.3389/fimmu.2023.1332626

Chicago

Yin, Taoyuan, Jingjing Wen, Simiao Xu, Lin Chen, Zhenxiong Zhang, Shutao Pan, Min Zhou, et al. 2024. “An E3 Ubiquitin-Proteasome Gene Signature for Predicting Prognosis in Patients with Pancreatic Cancer.” Frontiers in Immunology 14 (January): 1332626. doi:10.3389/fimmu.2023.1332626.